
First patient treated in clinical trial of IBA's innovative ConformalFLASH® proton therapy for head and neck cancer.
IBA has treated the first patient in the C-FLASH-01 clinical trial, the first human study testing ConformalFLASH® proton therapy. This trial, conducted at Penn Medicine with FDA approval, explores the feasibility of using ultra-high dose rate proton ...





